Gene · 6041
Papers3,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| UCHL3 Regulates Subgenomic Flaviviral RNA Condensates to Promote Virus Propagation. | Adv Sci (Weinh) | 2026 | 42231789 | PubTator, text mining | PubMed |
| NRAS mRNA-Degrading Bifunctional Small Molecules Induce Diverse Cellular Morphological Changes in Cancer Cells. | JACS Au | 2026 | 42212085 | PubTator, text mining | PubMed |
| SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | J Biol Chem | 2026 | 42190814 | PubTator, text mining | PubMed |
| Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research. | Microb Biotechnol | 2026 | 42171504 | PubTator, text mining | PubMed |
| Correction: Liquid-liquid phase separation mediated immune evasion of respiratory syncytial virus against oligoadenylate synthetase-RNase L pathway. | PLoS Pathog | 2026 | 42085433 | PubTator, text mining | PubMed |
| RNase-L links innate immunity to gestational glucose homeostasis. | J Formos Med Assoc | 2026 | 42069498 | PubTator, text mining | PubMed |
| Non-canonical proteolytic activation of RNase L by SARS-CoV-2 3CLpro offsets inactivation of OAS1 p46 antiviral signaling. | Cell Rep | 2026 | 42001419 | PubTator, text mining | PubMed |
| SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | bioRxiv | 2026 | 41959085 | PubTator, text mining | PubMed |
| RNase L Regulates Antiviral Responsiveness through Cleavage of XBP1 mRNA. | bioRxiv | 2026 | 41928978 | PubTator, text mining | PubMed |
| Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by suppressing antiviral responses. | PLoS Biol | 2026 | 41920932 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation mediated immune evasion of respiratory syncytial virus against oligoadenylate synthetase-RNase L pathway. | PLoS Pathog | 2026 | 41894421 | PubTator, text mining | PubMed |
| Sensing of double-stranded RNA in human cells: molecular mechanisms and cellular consequences. | Biochem Soc Trans | 2026 | 41873699 | PubTator, text mining | PubMed |
| Dual regulation of HEPN RNase in fused MNT-HEPN toxin-antitoxin systems via protein OligoAMPylation and oligomerization. | Nucleic Acids Res | 2026 | 41854079 | PubTator, text mining | PubMed |
| Degron models: a toolbox for rapid in vivo depletion of essential proteins regulating mRNA metabolism. | Commun Biol | 2026 | 41851445 | PubTator, text mining | PubMed |
| Defects in intron recycling suppress the antiviral response via a mechanism of intronic endogenous dsRNA. | J Exp Med | 2026 | 41817448 | PubTator, text mining | PubMed |
| Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis, Treatment, and Prevention. | MedComm (2020) | 2026 | 41799932 | PubTator, text mining | PubMed |
| Experimental adaptation of pigeon rotavirus A (pRVA) in human colorectal cancer cells reveals interferon-driven host responses and immune checkpoint modulation. | New Microbes New Infect | 2026 | 41783245 | PubTator, text mining | PubMed |
| Single vs dual genetic disease in children with congenital anomalies and solid tumors. | Genet Med Open | 2026 | 41783072 | PubTator, text mining | PubMed |
| RNase L regulates the antiviral proteome by accelerating mRNA decay, inhibiting nuclear mRNA export, and repressing transcription. | Cell Rep | 2026 | 41758647 | PubTator, text mining | PubMed |
| Differential assembly of RNP granules via activation of distinct dsRNA sensors by adenovirus mutants. | bioRxiv | 2026 | 41756847 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6041/papers?page=2